To further determine whether CASP1 and CASP4/11 pathways are pathophysiologically relevant to CKD, we found that the expression levels of CASP1 and CASP4 were significantly increased in the kidneys of patients with CKD (Figure 2, A and B). Here, CASP1 is linked to chronic kidney disease.